At a glance
ClinicalIndex Comparison Record- ✓Females aged 20 years or older
- ✓Histologically confirmed squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of uterine cervix
- ✓FIGO stage IB1 with stromal invasion >5 mm or lesion size 7 mm to ≤4 cm
- ✓Undergoing type B or C hysterectomy (Querleu-Morrow classification)
- ✕Any histological type other than squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- ✕Tumor size greater than 4 cm
- ✕FIGO stage less than IA2 or greater than IB2
- ✕Evidence of metastatic disease, enlarged pelvic/aortic lymph nodes >2 cm, or histologically positive lymph nodes
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Of Laparoscopic or Robotic Radical Hysterectomy Using Endoscopic sTapler for Inhibiting tumOr Spillage of Cervical Neoplasms (SOLUTION): a Phase II Study
In Brief
A clinical study evaluating Minimally invasive surgery using endoscopic stapler for Cervical Cancer and 2 related conditions. Currently recruiting, targeting 124 participants across 3 sites.
Detailed Summary
The SOLUTION trial aims to show the efficacy and safety of performing radical hysterectomy by minimally invasive surgery using an endoscopic stapler in patients with cervical cancer stage IB1 (FIGO staging 2009) and thus to prove that minimally invasive surgery is non-inferior to open surgery.
Study Details
Timeline
Interventions
Radical hysterectomy by minimally invasive surgery (laparoscopic or robotic) will be done with the help of an endoscopic stapler in cutting and suturing the uterine cervix.